Osaic Holdings
RDY icon

Osaic Holdings’s Dr. Reddy's Laboratories RDY Stock Holding History

Osaic Holdings’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$614K Buy
42,357
+5,107
+14% +$68.9K ﹤0.01% 3487
2026
Q1 		$516K Buy
37,250
+14,002
+60% +$195K ﹤0.01% 3318
2025
Q4 		$326K Buy
23,248
+1,625
+8% +$22.8K ﹤0.01% 3725
2025
Q3 		$302K Buy
21,623
+10,233
+90% +$147K ﹤0.01% 3862
2025
Q2 		$158K Buy
11,390
+10,445
+1,105% +$149K ﹤0.01% 4130
2025
Q1 		$12.5K Sell
945
-34,574
-97% -$477K ﹤0.01% 5663
2024
Q4 		$561K Buy
35,519
+1,859
+6% +$27.9K ﹤0.01% 2688
2024
Q3 		$535K Hold
33,660
– – ﹤0.01% 2808
2024
Q2 		$513K Sell
33,660
-1,025
-3% -$14.7K ﹤0.01% 2744
2024
Q1 		$509K Sell
34,685
-11,395
-25% -$166K ﹤0.01% 2922
2023
Q4 		$641K Sell
46,080
-29,155
-39% -$390K ﹤0.01% 2942
2023
Q3 		$1.01M Buy
75,235
+50,300
+202% +$681K ﹤0.01% 2626
2023
Q2 		$315K Sell
24,935
-6,600
-21% -$77K ﹤0.01% 3546
2023
Q1 		$359K Buy
31,535
+26,980
+592% +$291K ﹤0.01% 3391
2022
Q4 		$47.1K Sell
4,555
-5,410
-54% -$58.4K ﹤0.01% 4982
2022
Q3 		$104K Buy
9,965
+4,810
+93% +$51.2K ﹤0.01% 4340
2022
Q2 		$58K Sell
5,155
-465
-8% -$5.06K ﹤0.01% 4848
2022
Q1 		$63K Sell
5,620
-2,385
-30% -$27K ﹤0.01% 4927
2021
Q4 		$105K Sell
8,005
-870
-10% -$11K ﹤0.01% 4561
2021
Q3 		$116K Sell
8,875
-295
-3% -$3.93K ﹤0.01% 4401
2021
Q2 		$136K Sell
9,170
-18,515
-67% -$259K ﹤0.01% 4217
2021
Q1 		$340K Buy
27,685
+95
+0.3% +$1.22K ﹤0.01% 3268
2020
Q4 		$393K Sell
27,590
-5
-0% -$67 ﹤0.01% 2866
2020
Q3 		$384K Buy
27,595
+7,215
+35% +$86K ﹤0.01% 2675
2020
Q2 		$216K Sell
20,380
-6,830
-25% -$69.5K ﹤0.01% 3065
2020
Q1 		$219K Buy
+27,210
New +$227K ﹤0.01% 2788

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Osaic Holdings's RDY Position: Q2 2026 in Review

Osaic Holdings increased its Dr. Reddy's Laboratories (RDY) stake by 14% in Q2 2026, buying an estimated $68.9K and bringing the position to 42,357 shares worth $614K. The position accounts for ﹤0.01% of the portfolio, ranked #3487.

Osaic Holdings first reported a position in RDY in Q1 2020 and has held it in 26 quarters since. The position peaked at $1.01M in Q3 2023. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Osaic Holdings held 42,357 shares of Dr. Reddy's Laboratories worth $614K as of Q2 2026.
  • Osaic Holdings bought 5,107 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $68.9K.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #3487 holding.
  • Osaic Holdings first reported a position in Dr. Reddy's Laboratories in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Dr. Reddy's Laboratories position peaked at $1.01M in Q3 2023.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.